SPDR S&P Biotech ETF
$121.84-0.64 %$XBI
About SPDR S&P Biotech ETF (XBI)
SPDR S&P Biotech ETF (XBI) is an exchange-traded fund established on January 31, 2006 and traded on the NYSE exchange. The fund manages approximately $8.10 billion in net assets, making it a significant ETF in its category.
With an expense ratio of 0.35%, SPDR S&P Biotech ETF is considered a low-cost investment option for investors seeking exposure to this asset class.
What You Need to Know About XBI
- Inception Date: January 31, 2006 - providing 20 years of track record
- Assets Under Management: $8.10 billion in net assets
- Expense Ratio: 0.35% annually
- Exchange: NYSE
- Type: Traditional ETF
Compare XBI with other investment options: ETF Screener | Stock Screener
Price History
▼-1.54%
Fund Details
Dividend Yield-0.13%
Inception Date2006-01-31
Net Assets$8.1B
Net Expense Ratio0.00%